Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | SLC13A5 | Q86YT5 | 7/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 3/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Eucomic Acid SCHEMBL23355983 | 1.00 | BLM (0.51) | BLMALDH1A1SLC13A5CA2CAMK2A | |
| Citric Acid SCHEMBL2169490 | 0.86 | ALDH1A1 (0.68) | BLMALDH1A1SLC13A5CA2CAMK2A | |
| SCHEMBL7300860 | 0.85 | SLC13A5 (0.56) | ALDH1A1SLC13A5KDM4EMEN1LMNA | |
| Citric Acid SCHEMBL28987020 | 0.84 | ALDH1A1 (0.54) | BLMALDH1A1SLC13A5CA2CAMK2A | |
| SCHEMBL10941763 | 0.83 | SLC13A5 (0.54) | ALDH1A1SLC13A5KDM4EMEN1LMNA | |
| SCHEMBL5343038 | 0.81 | BLM (0.56) | BLMALDH1A1CA2CAMK2AESR1 | |
| Citric Acid SCHEMBL28803585 | 0.81 | CA2 (0.57) | ALDH1A1SLC13A5CA2CAMK2AESR1 | |
| SCHEMBL559315 | 0.80 | CTBP2 (0.57) | BLMCA2CAMK2AESR1ESR2 | |
| SCHEMBL559316 | 0.80 | CTBP2 (0.57) | BLMCA2CAMK2AESR1ESR2 | |
| SCHEMBL10088121 | 0.79 | BLM (0.53) | BLMALDH1A1SLC13A5CA2CAMK2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023145880-A1 | GLUTAMINASE INHIBITOR | 国立大学法人富山大学 | 2023-08-03 | — | — | WO | disclosed |
| US-11365170-B2 | Non-solvate crystal of eucomic acid and method for producing same | KYOWA HAKKO BIO CO., LTD. (JP) | 2022-06-21 | — | — | US | disclosed |
| US-20210221764-A1 | NON-SOLVATE CRYSTAL OF EUCOMIC ACID AND METHOD FOR PRODUCING SAME | KYOWA HAKKO BIO CO., LTD. (JP) | 2021-07-22 | — | — | US | disclosed |
| EP-3822249-A1 | CRYSTAL OF EUCOMIC ACID NON-SOLVATE AND PRODUCTION METHOD THEREFOR | Kyowa Hakko Bio Co., Ltd. (JP) | 2021-05-19 | — | — | EP | disclosed |
| CN-103003292-B | Cosmetic composition | 娇兰有限公司 | 2016-06-29 | — | — | CN | disclosed |
| CN-103003292-B | Cosmetic composition | 娇兰有限公司 | 2016-06-29 | — | — | CN | disclosed |
| US-9012414-B2 | Cosmetic composition | GUERLAIN (FR) | 2015-04-21 | — | — | US | disclosed |
| US-9012414-B2 | Cosmetic composition | GUERLAIN (FR) | 2015-04-21 | — | — | US | disclosed |
| US-20130157968-A1 | COSMETIC COMPOSITION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-06-20 | — | — | US | disclosed |
| US-20130157968-A1 | COSMETIC COMPOSITION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-06-20 | — | — | US | disclosed |
| CN-103003292-A | Cosmetic composition | GUERLAIN | 2013-03-27 | — | — | CN | disclosed |
| CN-103003292-A | Cosmetic composition | GUERLAIN | 2013-03-27 | — | — | CN | disclosed |
| EP-2556080-A1 | COSMETIC COMPOSITION | Guerlain (FR) | 2013-02-13 | — | — | EP | disclosed |
| WO-2011125057-A4 | COSMETIC COMPOSITION | GUERLAIN (FR) | 2012-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130157968-A1 | COSMETIC COMPOSITION | H1-0, H1-2, H1-3 | BLM 4702/4885ALDH1A1 1287/4885SLC13A5 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.